The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0050
+0.0005 (11.11%)
Feb 10, 2026, 10:22 AM AEST

ASX:HPC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
4.342.67-8.1-10.61-8.95-0.74
Depreciation & Amortization
----00.02
Other Amortization
----0.32-
Loss (Gain) From Sale of Assets
---0.03--2.75
Other Operating Activities
-8.85-7.621.792.12.530.23
Change in Accounts Receivable
1.41.4-0.44-0.29-0.24-0.19
Change in Inventory
0.860.860.85-1.72-0.21-0.72
Change in Accounts Payable
-1.42-1.420.170.07-0.130.67
Change in Other Net Operating Assets
0.240.24-00.67-1.4-0.38
Operating Cash Flow
-3.43-3.88-5.73-9.75-8.08-3.86
Capital Expenditures
------0.02
Sale of Property, Plant & Equipment
9.449.44----
Sale (Purchase) of Intangibles
-----2.75
Investing Cash Flow
9.449.44---2.73
Long-Term Debt Issued
-1.110.254.08--
Long-Term Debt Repaid
--5.15----
Net Debt Issued (Repaid)
-5.15-4.040.254.08--
Issuance of Common Stock
0.51-2.7-18.45-
Other Financing Activities
0-0.02-0.24--1.42-
Financing Cash Flow
-4.64-4.072.724.0817.03-
Foreign Exchange Rate Adjustments
-0.12-0.120.17-0.310.080.04
Net Cash Flow
1.261.38-2.85-5.989.03-1.09
Free Cash Flow
-3.43-3.88-5.73-9.75-8.08-3.88
Free Cash Flow Margin
-117.04%-121.03%-133.22%-107.16%-131.84%-103.29%
Free Cash Flow Per Share
-0.01-0.01-0.03-0.06-0.11-0.06
Cash Interest Paid
0.590.690.53--0.01
Levered Free Cash Flow
-1.88-1.18-2.35-5.48-6.340.09
Unlevered Free Cash Flow
-1.34-0.08-1.95-5.43-4.750.1
Change in Working Capital
1.081.080.58-1.27-1.98-0.62
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.